发明名称 |
NOVEL 2-HETEROARYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVE |
摘要 |
<p>A glucokinase activator; a therapeutic and/or preventive agent for diabetes or a therapeutic and/or preventive agent for complications of diabetes, such as retinopathy, nephropathy, neurosis, ischemic heart disease, and arteriosclerosis; and a therapeutic and/or preventive agent for obesity. The glucokinase activator is characterized by containing either a 2-heteroaryl-substituted benzimidazole derivative represented by the general formula (I-0): 1 RING A (I-0) [wherein X represents carbon or nitrogen; X1, X2, X3, and X4 each independently represents carbon or nitrogen; ring A represents, e.g., a 5- or 6-membered nitrogenous aromatic heterocycle represented by the formula (II): 1 RING A (II) (wherein X represents carbon or nitrogen); R<1> represents aryl, etc.; R<2> represents hydroxy, etc.; R<3> represents -(C1-6 alkyl), etc.; R<4> represents -(C1-6 alkyl), etc.; X5 represents -O-, etc.; a is 1, 2, or 3; q is an integer of 0 to 2; and m is an integer of 0 to 2] or a pharmaceutically acceptable salt of the derivative.</p> |
申请公布号 |
WO2005063738(A1) |
申请公布日期 |
2005.07.14 |
申请号 |
WO2004JP19843 |
申请日期 |
2004.12.28 |
申请人 |
BANYU PHARMACEUTICAL CO.,LTD;NONOSHITA, KATSUMASA;OGINO, YOSHIO;ISHIKAWA, MAKOTO;SAKAI, FUMIKO;NAKASHIMA, HIROSHI;NAGAE, YOSHIKAZU;TSUKAHARA, DAISUKE;ARAKAWA, KEISUKE;NISHIMURA, TERUYUKI;EIKI, JUN-ICHI |
发明人 |
NONOSHITA, KATSUMASA;OGINO, YOSHIO;ISHIKAWA, MAKOTO;SAKAI, FUMIKO;NAKASHIMA, HIROSHI;NAGAE, YOSHIKAZU;TSUKAHARA, DAISUKE;ARAKAWA, KEISUKE;NISHIMURA, TERUYUKI;EIKI, JUN-ICHI |
分类号 |
A61K31/4192;A61K31/4196;A61K31/4245;A61K31/426;A61K31/427;A61K31/433;A61K31/4439;A61K31/444;A61K31/4709;A61K31/496;A61K31/497;A61K31/506;A61K31/5377;A61P3/04;A61P3/10;A61P13/12;A61P25/00;A61P43/00;C07D401/04;C07D401/12;C07D401/14;C07D413/04;C07D413/14;C07D417/04;(IPC1-7):C07D401/04;A61K31/537;A61K31/470;A61K31/443;A61K31/424;A61K31/419 |
主分类号 |
A61K31/4192 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|